Why Choose StemCyte?
StemCyte is the Safest and the most Secured bank to Preserve your Baby’s Cord Blood!
Global Presence
StemCyte is a global cord blood bank and pioneer in regenerative therapeutics catering to the vast ethnically diverse groups for more than two decades that operates internationally in the USA (1997), Taiwan (2000) and India (2010).
Association with Healthcare Giants
In India, StemCyte is a joint venture with leading healthcare giants, Apollo Hospitals and Cadila Pharmaceuticals. By Leveraging its vast medical expertise & technological advantage, it gives a distinct advantage to StemCyte’s customers.
State-of-the-art Facility
StemCyte is a global cord blood bank and pioneer in regenerative therapeutics catering to the vast ethnically diverse groups for more than two decades that operates internationally in the USA (1997), Taiwan (2000) and India (2010).
Hybrid Model
StemCyte is a global cord blood bank and pioneer in regenerative therapeutics catering to the vast ethnically diverse groups for more than two decades that operates internationally in the USA (1997), Taiwan (2000) and India (2010).
Plasma Depletion Technology
PD Technology is a superior method for Cord Blood processing and its StemCyte’s Patented Technique.
Exclusive advantages of PD Technology are:
→ It’s a Chemical-free process
→ Up to 75 ml Storage
→ More TNCs, CD34+ cells recovery
→ Superior engraftment
→ Higher transplant-related survival
→ High disease-free survival
Impeccable Transplant Experience
StemCyte has released more than 2300+ cord blood units in 350 transplant centers worldwide, including 48 Units in India. This includes treatment of adult patients and treatment of rare diseases including Thalassemia, AML (Acute Myeloid Leukemia), ALL (Acute Lymphoblastic Leukemia), Hurler’s Syndrome, Fanconi Anemia, and many more.
In India, StemCyte has associated with leading transplant centers to provide high-quality cord blood units for transplantation which includes AIIMS Delhi, Apollo Specialty Hospital – Chennai, Gujarat Cancer and Research Institute – Ahmedabad, Deenanath Mangeshkar Hospital – Pune, Apollo Gleneagles Hospital – Kolkata, Apollo Hospital – Hyderabad and many more.
Accreditations
StemCyte is the one and only cord blood bank in India with FACT Accreditation. FACT is the accrediting agency that addresses all quality aspects of cord blood collection, processing, testing, banking, selection and release.
Along with this StemCyte India is accredited with AABB, NABL, FDA, ISO-9001 and is a member of Cord Blood Association.
StemCyte’s highest accreditations gives confidence to parents and physicians and ensures highest quality standards.
StemCyte India’s Advanced Collection Kit Box
StemCyte’s advanced collection kit box ensures Sterile, Safe and Smooth collection and transportation of Cord Blood Units.
→ Water Proof
→ Maintains Optimum Temperature
→ Shockproof
→ Highly Tensile
→ Very Light Weight
Life Saver Guarantee
StemCyte takes responsibility even post-transplant by providing support under Life Saver Guarantee. If for any reason engraftment fails, StemCyte will provide a replacement cord blood unit from its public inventory, at NO extra cost.
Active Clinical Trials
Today, there are many active clinical trials going on for testing the efficacy of cord blood stem cells on numerous health conditions to unlock the true potential of cord blood stem cells. StemCyte partners with renowned medical institutions on FDA-Approved clinical trials in the treatment of many conditions such as acute and chronic stroke, cerebral palsy, autism and spinal cord injury.
